Using a mouse model, scientists have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD). This discovery could lead to the development of drugs based on glycans – biological sugar molecules – for the treatment of diseases such as COPD, which is the fourth leading cause of death worldwide.
from Top Health News – ScienceDaily http://ift.tt/2iohQeq
from Tumblr http://ift.tt/2hLfWUD
No comments:
Post a Comment